Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:09 PM
Ignite Modification Date: 2025-12-25 @ 12:22 PM
NCT ID: NCT00570661
Description: None
Frequency Threshold: 5
Time Frame: At weeks 1, 2, 4, 6, 8, 10, 12 (end of treatment) and FU1 and FU3
Study: NCT00570661
Study Brief: Open Label, Multicentre Trial to Assess Safety and Efficacy of ITF2357 in Active Systemic Juvenile Idiopathic Arthritis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
IT2357 - Safety Population Safety population: all recruited patients who received at least one dose of the study medication. 0 None 2 17 14 17 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Cellulitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (11.1) View
Varicella SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (11.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Atelectasis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (11.1) View
Oropharyngeal pain SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (11.1) View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA (11.1) View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA (11.1) View
Depression SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (11.1) View
Enteritis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (11.1) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (11.1) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (11.1) View
Haematuria SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (11.1) View
Nephrolithiasis SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (11.1) View
Dermatitis contact SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (11.1) View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (11.1) View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (11.1) View
Arthritis SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (11.1) View
Joint swelling SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (11.1) View
Influenza SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (11.1) View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (11.1) View
Otitis media SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (11.1) View
Otitis media acute SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (11.1) View
Pharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (11.1) View
Tonsillitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (11.1) View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (11.1) View
Injury SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (11.1) View
Electrocardiogram QT prolonged SYSTEMATIC_ASSESSMENT Investigations MedDRA (11.1) View